Danone announced on January 23, 2026 that it is voluntarily withdrawing a limited number of infant formula batches produced in Ireland from selected markets in response to updated guidance from local food safety authorities. The recall affects fewer than 0.2% of Danone’s global baby nutrition output and applies only to products distributed through hospital and pharmacy channels in five European countries. Danone emphasized that both routine in-house controls and additional targeted analyses confirm full compliance with all safety regulations, and no cases of contamination have been reported.

In its press release, Danone reiterated its commitment to food safety, citing a comprehensive testing protocol that covers raw materials, in-process checks and finished goods. The company’s Specialized Nutrition division, which accounted for approximately €6.5 billion in 2024 sales, continues to operate under unchanged safety standards. Danone has activated a dedicated consumer careline and is providing batch-specific information online to healthcare professionals and parents to ensure transparency and maintain confidence in its Aptamil, Nutrilon and Cow & Gate infant formula brands.

While Danone’s overall 2024 revenues reached €27.4 billion, the baby formula segment contributes roughly 12% of group sales. The targeted recall is expected to incur non-material logistical costs estimated at €10 million and negligible impact on full-year earnings per share. Danone confirmed that no production lines will be idled and that alternative product supply will prevent stock-outs in key markets. The company also reaffirmed its 2026 financial guidance of low single-digit organic sales growth and mid-single-digit margin expansion.

In parallel with the recall, Danone has accelerated investments in its global quality assurance infrastructure, including the rollout of enhanced digital traceability systems across five manufacturing sites by mid-2026. This initiative supports the company’s Renew strategic plan to restore long-term growth and competitiveness in its three health-focused segments: Essential Dairy & Plant-Based, Waters, and Specialized Nutrition. With over 90,000 employees and B Corp certification achieved in 2025, Danone aims to reinforce trust with stakeholders while driving sustainable, nutrition-led innovation.